SwertiajaponinCAS# 6980-25-2 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 6980-25-2 | SDF | Download SDF |
PubChem ID | 442659 | Appearance | Yellow powder |
Formula | C22H22O11 | M.Wt | 462.4 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-methoxy-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one | ||
SMILES | COC1=C(C(=C2C(=C1)OC(=CC2=O)C3=CC(=C(C=C3)O)O)O)C4C(C(C(C(O4)CO)O)O)O | ||
Standard InChIKey | DLVLXOYLQKCAME-DGHBBABESA-N | ||
Standard InChI | InChI=1S/C22H22O11/c1-31-13-6-14-16(11(26)5-12(32-14)8-2-3-9(24)10(25)4-8)19(28)17(13)22-21(30)20(29)18(27)15(7-23)33-22/h2-6,15,18,20-25,27-30H,7H2,1H3/t15-,18-,20+,21-,22+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Swertiajaponin possesses antimicrobial activity. |
Targets | Antifection |
Swertiajaponin Dilution Calculator
Swertiajaponin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.1626 mL | 10.8131 mL | 21.6263 mL | 43.2526 mL | 54.0657 mL |
5 mM | 0.4325 mL | 2.1626 mL | 4.3253 mL | 8.6505 mL | 10.8131 mL |
10 mM | 0.2163 mL | 1.0813 mL | 2.1626 mL | 4.3253 mL | 5.4066 mL |
50 mM | 0.0433 mL | 0.2163 mL | 0.4325 mL | 0.8651 mL | 1.0813 mL |
100 mM | 0.0216 mL | 0.1081 mL | 0.2163 mL | 0.4325 mL | 0.5407 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- UAMC 00039 dihydrochloride
Catalog No.:BCC6340
CAS No.:697797-51-6
- Elvitegravir (GS-9137)
Catalog No.:BCC2134
CAS No.:697761-98-1
- Antibiotic BU 2313A
Catalog No.:BCN1846
CAS No.:69774-86-3
- 4-(3,4-Dimethoxyphenyl)-3-buten-1-ol
Catalog No.:BCN4258
CAS No.:69768-97-4
- W-9 hydrochloride
Catalog No.:BCC6623
CAS No.:69762-85-2
- BIS-TRIS
Catalog No.:BCC8028
CAS No.:6976-37-0
- CRSP-1
Catalog No.:BCC6043
CAS No.:697327-12-1
- Silvestrol
Catalog No.:BCC1948
CAS No.:697235-38-4
- 6-Amino-1-methyl-5-nitrosouracil
Catalog No.:BCC8756
CAS No.:6972-78-7
- DCB
Catalog No.:BCC7212
CAS No.:6971-97-7
- VIP (6-28) (human, rat, porcine, bovine)
Catalog No.:BCC5838
CAS No.:69698-54-0
- 2,5-Dimethylchroman-4-one
Catalog No.:BCN7200
CAS No.:69687-87-2
- 2,7-Dihydroxy-2H-1,4-benzoxazin-3(4H)-one
Catalog No.:BCN1374
CAS No.:69804-59-7
- Agarotetrol
Catalog No.:BCN6763
CAS No.:69809-22-9
- Noradrenaline Bitartrate
Catalog No.:BCC8343
CAS No.:51-40-1
- Neratinib (HKI-272)
Catalog No.:BCC3685
CAS No.:698387-09-6
- Bourjotinolone A
Catalog No.:BCN4259
CAS No.:6985-35-9
- Boc-Glu(OtBu)-ONp
Catalog No.:BCC3393
CAS No.:69876-58-0
- Petunidin-3-O-glucoside chloride
Catalog No.:BCN3025
CAS No.:6988-81-4
- Pseudoginsenoside F11
Catalog No.:BCN1062
CAS No.:69884-00-0
- Atractylone
Catalog No.:BCN3048
CAS No.:6989-21-5
- Bayogenin
Catalog No.:BCN2458
CAS No.:6989-24-8
- Evodine
Catalog No.:BCN2630
CAS No.:6989-38-4
- (+)-Isoajmaline
Catalog No.:BCN3425
CAS No.:6989-79-3
Inhibitory effect of three C-glycosylflavonoids from Cymbopogon citratus (Lemongrass) on human low density lipoprotein oxidation.[Pubmed:19924037]
Molecules. 2009 Sep 30;14(10):3906-13.
This study assessed the inhibitory effect of three C-glycosylflavonoids from Cymbopogon citratus leaves--isoorientin (1), Swertiajaponin (2) and isoorientin 2"-Orhamnoside (3)--on human LDL oxidation. Isolated LDL was incubated with compounds 1-3 and the kinetics of lipid peroxidation were assessed by conjugated diene and malondialdehyde-thiobarbituric acid reactive substances (MDA-TBARS) formation after addition of copper ions. Significant differences (p < 0.05) between the lag time phase of the control and the lag time phase in the presence of the compounds 1 (0.25 microM) and 2 (0.50 microM) were observed. After five hours of incubation all three compounds showed a significant inhibitory effect on MDA-TBARS formation with respect to the control. After six hours of incubation only compound 1 kept a remarkable antioxidant effect. This study demonstrates that isoorientin (1) is an effective inhibitor of in vitro LDL oxidation. As oxidative damage to LDL is a key event in the formation of atherosclerotic lesions, the use of this natural antioxidant may be beneficial to prevent or attenuate atherosclerosis.
Free radical scavengers and antioxidants from Lemongrass (Cymbopogon citratus (DC.) Stapf.).[Pubmed:15796587]
J Agric Food Chem. 2005 Apr 6;53(7):2511-7.
Methanol, MeOH/water extracts, infusion, and decoction of Cymbopogon citratus were assessed for free radical scavenging effects measured by the bleaching of the 1,1-diphenyl-2-picryl-hydrazyl (DPPH) radical, scavenging of the superoxide anion, and inhibition of the enzyme xanthine oxidase (XO) and lipid peroxidation in human erythrocytes. The extracts presented effect in the DPPH and superoxide anion assay, with values ranging between 40 and 68% and 15-32% at 33 and 50 microg/mL, respectively, inhibited lipid peroxidation in erythrocytes by 19-71% at 500 microg/mL and were inactive toward the XO at 50 microg/mL. Isoorientin, isoscoparin, Swertiajaponin, isoorientin 2' '-O-rhamnoside, orientin, chlorogenic acid, and caffeic acid were isolated and identified by spectroscopic methods. Isoorientin and orientin presented similar activities toward the DPPH (IC(50): 9-10 microM) and inhibited lipid peroxidation by 70% at 100 microg/mL. Caffeic and chlorogenic acid were active superoxide anion scavengers with IC(50) values of 68.8 and 54.2 microM, respectively, and a strong effect toward DPPH. Caffeic acid inhibited lipid peroxidation by 85% at 100 microg/mL.